Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N, Samoilova A, Skornykova S, Tudor E, Variava E, Yablonskiy P, Everitt D, Wills GH, Sun E, Olugbosi M, Egizi E, Li M, Holsta A, Timm J, Bateson A, Crook AM, Fabiane SM, Hunt R, McHugh TD, Tweed CD, Foraida S, Mendel CM, Spigelman M; ZeNix Trial Team.
N Engl J Med. 2022 Sep 1;387(9):810-823. doi: 10.1056/NEJMoa2119430.
PMID:36053506
Steroid-responsive HIV optic neuropathy.
Burton BJ, Leff AP, Plant GT.
J Neuroophthalmol. 1998 Mar;18(1):25-9.
PMID:9532535
Ethambutol induced toxic optic neuropathy in HIV positive patients.
Mustak H, Rogers G, Cook C.
Int J Ophthalmol. 2013 Aug 18;6(4):542-5. doi: 10.3980/j.issn.2222-3959.2013.04.25. eCollection 2013.
PMID:23991394
Optic neuropathy secondary to syphilis in an HIV negative patient.
Berrozpe-Villabona C, Santos-Bueso E, Bañeros-Rojas P, Aguilar Munoa S, Saenz-Francés F, Díaz-Valle D, Martínez-de-la-Casa JM, García-Feijoo J.
Relapsing-remitting Optic Neuropathy in an HIV-infected Patient: Secondary Auto-immune Optic Neuropathy or Infectious Optic Neuropathy? A Case Report and Review of the Literature.
Coutel M, Flamant R, El Sankari S, Belkhir L, Duprez T, Boschi A.
Neuroophthalmology. 2021 Jun 11;46(4):236-241. doi: 10.1080/01658107.2021.1933078. eCollection 2022.
PMID:35859626
Ethambutol/Linezolid Toxic Optic Neuropathy.
Libershteyn Y.
Optom Vis Sci. 2016 Feb;93(2):211-7. doi: 10.1097/OPX.0000000000000783.
PMID:26636399
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).